Roflast®

Roflast®

Therapeutic Segment:  Phosphodiesterase 4 inhibitor

Generic Name: Roflumilast

Indications:

For treatment of severe chronic obstructive pulmonary disease (COPD) (FEV1 post-bronchodilator less than 50% predicted) associated with chronic bronchitis in adult patients with a history of frequent exacerbations as add on to bronchodilator treatment.

Available as:

Tablets
  • 500 mcg